Skip to content
Search

Latest Stories

RPS president says “still a very long way to go to achieve gender equity” in pharmacy

There is still a long way to go to achieve gender equality in pharmacy in both academia and profession, Royal Pharmaceutical Society (RPS) president Claire Anderson said while addressing a webinar on ‘Driving equality for women in pharmacy today (November 19).

Sharing her personal experience, Anderson, who earlier worked as an academic, said: “I was the first ever female professor in the School of Pharmacy at Nottingham when I was appointed as professor in 2003, and at that point, only 11 per cent of professors in my university were female.”


She acknowledged that the situation has changed since then, but “there's still a very long way to go to achieve gender equity in most of academia, and in pharmacy, in particular.”

She added that the profession has ensured safe spaces for women but noted that is not enough, as gender equity is vital to achieve healthier and safer societies.

“And although our work on equality, diversity and inclusion is progressing very well, I think we're still not there. It's a journey and there's much to be achieved.”

Quoting a media investigation RPS CEO Paul Bennett said that only two per cent of pharmacy business owners are women, while 13 per cent are men.

He said: “Women in senior pharmacy leadership positions across our profession have much lower numbers than they would be if they reflect the numbers of females in the profession. And the bias remains in systems and structures, that mean the gender parity is not achieved.”

He added that gender disparity issue has been highlighted for over several years now, therefore, “we hold all of us in any position of influence to champion inclusive leadership and to support women from diverse backgrounds across all levels of policy to become leaders.”

It is the moral obligation of leaders to “use their influence to champion the rights of their female colleagues to grow in their careers and advanced in positions of leadership.”

Approving the view that gender equality in the pharmacy sector is still a far-fetched dream, head of Equality & Inclusion at NHS England, Harprit Hockley said that 78 per cent of the NHS staff comprises women but “that's not reflected in our senior roles or nor is it reflected in the decision making process.”

She explained that NHS has tried to debias individuals through training but noted that “one hour to three hours of training is not going to dismantle decades of that negative narrative.”

Therefore, the thrust needs to be on bringing in systematic changes and breaking down the barriers that obstruct achieving gender equity.

More For You

Omega Pharmacy in Derbyshire Finds New Owner in Just 18 Days

Omega Pharmacy

Christie & Co

Omega Pharmacy in Derbyshire sold in just 18 days

Omega Pharmacy in Derbyshire has found a new owner in less than three weeks after being put on the market.

The pharmacy was previously owned by husband-and-wife duo Manny and Poonam Rai, who decided to sell it after a short period of ownership to focus on their other pharmacy in Coventry, according to Christie & Co.

Keep ReadingShow less
DHSC announces second list of March 2025 price concessions

A price concession only applies for the month it is granted.

Getty Images

March price concessions list released; prescription charge remains unchanged

The Department of Health and Social Care (DHSC) has released a second list of price concessions for March 2025, following ongoing discussions with Community Pharmacy England (CPE) regarding medicine pricing concerns raised by pharmacy owners.

A price concession is introduced when pharmacy contractors are unable to source a drug at or below the reimbursement price set out in the Drug Tariff.

Keep ReadingShow less
AstraZeneca partners with CEPI to develop multi-specific influenza antibody

AstraZeneca-CEPI collaboration aims to increase global access to antibody-based interventions

Getty Images

AstraZeneca secures £33M CEPI funding to develop multi-specific influenza antibody

AstraZeneca has joined forces with the Coalition for Epidemic Preparedness Innovations (CEPI) to advance an innovative antibody technology that could help tackle future infectious disease outbreaks and pandemics swiftly and more affordably.

CEPI will provide up to US$43.5 million (£33.6 million) in funding to support the biopharmaceutical company in evaluating a type of antibody, known as a VHH (Variable Heavy domain of a Heavy chain -only antibody), through preclinical proof-of-concept studies and Phase 1 clinical trials.

Keep ReadingShow less
Community Pharmacy Patient Safety Group announces new vice-chair

Martin Sadr-Kazemi 's appointment follows the passing of Dr. José Moss in January 2025.

Martin Sadr-Kazemi appointed vice-chair of Community Pharmacy Patient Safety Group

The Community Pharmacy Patient Safety Group (CPPSG) has announced the appointment of Martin Sadr-Kazemi as its new vice-chair.

Martin, currently the medication safety officer and deputy superintendent pharmacist at Rowlands Pharmacy, has been an integral member of the CPPSG since its formation a decade ago, actively contributing to various initiatives.

Keep ReadingShow less
"My work benefits all across London," says ambulance pharmacy technician

Mahrukh Jaffar

Pic credit: London Ambulance Service

"My work benefits all across London," says ambulance pharmacy technician

Mahrukh Jaffar will create history when she becomes the first apprentice to become a qualified pharmacy technician through the London Ambulance Service.

Jaffar is just days away from completing her registration with the General Pharmaceutical Council.

Keep ReadingShow less